Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hemostatic Disorders 1Agnosia 1

Interventions

Morphine 2Bupivacaine 2Anesthesia, Local 2Analgesia, Epidural 2engage 8200 1Transdermal Patch 1Touch 1Telemedicine 1Surgical Instruments 1Ropivacaine 1Radiosurgery 1Radiofrequency Ablation 1Psilocybin 1Palliative Care 1Methods 1Ketorolac 1Hydromorphone 1Exercise 1Epinephrine 1Electroencephalography 1Dipyrone 1Cryosurgery 1Clonidine 1Capsaicin 1Botulinum Toxins, Type A 1Anesthesia, Spinal 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Agnosia × Dipyrone × Clear all
NCT07384013 2026-02-03

Study Protocol: Impact of Metamizole (OptalginĀ®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Rambam Health Care Campus

Phase NA Recruiting
30 enrolled

Agnosia, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚔